Nothing Special   »   [go: up one dir, main page]

FI20041425A0 - Transmukosaalinen veterinäärinen koostumus - Google Patents

Transmukosaalinen veterinäärinen koostumus

Info

Publication number
FI20041425A0
FI20041425A0 FI20041425A FI20041425A FI20041425A0 FI 20041425 A0 FI20041425 A0 FI 20041425A0 FI 20041425 A FI20041425 A FI 20041425A FI 20041425 A FI20041425 A FI 20041425A FI 20041425 A0 FI20041425 A0 FI 20041425A0
Authority
FI
Finland
Prior art keywords
transmucosal
veterinary composition
veterinary
composition
transmucosal veterinary
Prior art date
Application number
FI20041425A
Other languages
English (en)
Swedish (sv)
Inventor
Mirja Huhtinen
Piritta Koistinen
Lasse Leino
Maria Rantala
Helena Kaukinen
Ursin Kaija Af
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20041425A priority Critical patent/FI20041425A0/fi
Publication of FI20041425A0 publication Critical patent/FI20041425A0/fi
Priority to BRPI0517719A priority patent/BRPI0517719B1/pt
Priority to NZ554521A priority patent/NZ554521A/en
Priority to DK05804165.8T priority patent/DK1811995T3/da
Priority to CA2583876A priority patent/CA2583876C/en
Priority to JP2007539597A priority patent/JP4996472B2/ja
Priority to SI200531588T priority patent/SI1811995T1/sl
Priority to KR1020077009256A priority patent/KR101257672B1/ko
Priority to US11/667,100 priority patent/US7863311B2/en
Priority to EP05804165A priority patent/EP1811995B1/en
Priority to RS20120440A priority patent/RS52504B/en
Priority to PL05804165T priority patent/PL1811995T3/pl
Priority to PT05804165T priority patent/PT1811995E/pt
Priority to AU2005300451A priority patent/AU2005300451B2/en
Priority to PCT/FI2005/000470 priority patent/WO2006048501A1/en
Priority to MX2007005238A priority patent/MX2007005238A/es
Priority to ES05804165T priority patent/ES2388442T3/es
Priority to ARP050104652A priority patent/AR054987A1/es
Priority to IL182541A priority patent/IL182541A/en
Priority to ZA200703486A priority patent/ZA200703486B/en
Priority to NO20072864A priority patent/NO338158B1/no
Priority to US12/953,691 priority patent/US8309591B2/en
Priority to CY20121100944T priority patent/CY1113730T1/el
Priority to HRP20120856TT priority patent/HRP20120856T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
FI20041425A 2004-11-05 2004-11-05 Transmukosaalinen veterinäärinen koostumus FI20041425A0 (fi)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FI20041425A FI20041425A0 (fi) 2004-11-05 2004-11-05 Transmukosaalinen veterinäärinen koostumus
ES05804165T ES2388442T3 (es) 2004-11-05 2005-11-03 Composición veterinaria transmucosa que comprende detomidina
RS20120440A RS52504B (en) 2004-11-05 2005-11-03 TRANSMUCOSE VETERINARY MIXTURE CONTAINING DETOMIDINE
PT05804165T PT1811995E (pt) 2004-11-05 2005-11-03 Composição veterinária transmucosa compreendendo detomidina
DK05804165.8T DK1811995T3 (da) 2004-11-05 2005-11-03 En transmucosal veterinær sammensætning omfattende detomidin
CA2583876A CA2583876C (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine
JP2007539597A JP4996472B2 (ja) 2004-11-05 2005-11-03 デトミジンを含む経粘膜動物用組成物
SI200531588T SI1811995T1 (sl) 2004-11-05 2005-11-03 Transmukozni veterinarski sestavek, ki obsega detomidin
KR1020077009256A KR101257672B1 (ko) 2004-11-05 2005-11-03 경점막 수의학적 조성물
US11/667,100 US7863311B2 (en) 2004-11-05 2005-11-03 Transmucosal veterinary composition comprising detomidine
EP05804165A EP1811995B1 (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine
BRPI0517719A BRPI0517719B1 (pt) 2004-11-05 2005-11-03 composição veterinária farmacêutica na forma de um gel transmucosal e kit veterinário
PL05804165T PL1811995T3 (pl) 2004-11-05 2005-11-03 Przezśluzówkowa kompozycja weterynaryjna zawierająca detomidynę
NZ554521A NZ554521A (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine
AU2005300451A AU2005300451B2 (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine
PCT/FI2005/000470 WO2006048501A1 (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine
MX2007005238A MX2007005238A (es) 2004-11-05 2005-11-03 Una composicion veterinaria transmucosal que comprende detomidina.
ARP050104652A AR054987A1 (es) 2004-11-05 2005-11-04 Composicion veterinaria trasmucosal
IL182541A IL182541A (en) 2004-11-05 2007-04-12 Pharmaceutical veterinary composition in the form of transmucosal gel, kit and method thereof
ZA200703486A ZA200703486B (en) 2004-11-05 2007-04-30 An transmucosal veterinary composition comprising detomidine
NO20072864A NO338158B1 (no) 2004-11-05 2007-06-05 En transmukosal veterinærsammensetning som omfatter detomidin
US12/953,691 US8309591B2 (en) 2004-11-05 2010-11-24 Transmucosal veterinary composition comprising detomidine
CY20121100944T CY1113730T1 (el) 2004-11-05 2012-10-12 Μια δiαβλεννογονiκη κτηνιατρικη συνθεση η οποια περιλαμβανει δετομιδινη
HRP20120856TT HRP20120856T1 (hr) 2004-11-05 2012-10-23 Transmukozni veterinarski pripravak koji sadrži detomidin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20041425A FI20041425A0 (fi) 2004-11-05 2004-11-05 Transmukosaalinen veterinäärinen koostumus

Publications (1)

Publication Number Publication Date
FI20041425A0 true FI20041425A0 (fi) 2004-11-05

Family

ID=33515193

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20041425A FI20041425A0 (fi) 2004-11-05 2004-11-05 Transmukosaalinen veterinäärinen koostumus

Country Status (22)

Country Link
US (2) US7863311B2 (fi)
EP (1) EP1811995B1 (fi)
JP (1) JP4996472B2 (fi)
KR (1) KR101257672B1 (fi)
AR (1) AR054987A1 (fi)
AU (1) AU2005300451B2 (fi)
BR (1) BRPI0517719B1 (fi)
CA (1) CA2583876C (fi)
DK (1) DK1811995T3 (fi)
ES (1) ES2388442T3 (fi)
FI (1) FI20041425A0 (fi)
HR (1) HRP20120856T1 (fi)
IL (1) IL182541A (fi)
MX (1) MX2007005238A (fi)
NO (1) NO338158B1 (fi)
NZ (1) NZ554521A (fi)
PL (1) PL1811995T3 (fi)
PT (1) PT1811995E (fi)
RS (1) RS52504B (fi)
SI (1) SI1811995T1 (fi)
WO (1) WO2006048501A1 (fi)
ZA (1) ZA200703486B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784134B1 (ko) 2006-10-09 2007-12-12 주식회사 대웅 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물
US8535713B2 (en) * 2007-04-04 2013-09-17 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
WO2011027811A1 (ja) * 2009-09-04 2011-03-10 株式会社 資生堂 Ｏ／ｗ乳化組成物の製造方法
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
AU2012379005B2 (en) * 2012-05-02 2017-12-21 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction
FR2990134B1 (fr) * 2012-05-07 2014-11-21 Anaconda Pharma Composition pharmaceutique d'un inhibiteur du virus du papillome
MX368880B (es) * 2012-10-15 2019-10-21 Orion Corp Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal.
BR112015014092A2 (pt) * 2012-12-21 2017-07-11 Teva Pharma administração oral transmucosal de acetato de glatirâmer
FI127534B (fi) * 2014-11-10 2018-08-31 Vetcare Oy Substituoitua bentsofurokinolitsiinia ja ɑ2-adrenergista agonistia käsittävät koostumukset
IL266448B2 (en) * 2017-01-06 2023-11-01 Clexio Biosciences Ltd Topical datumidine formulations
JP2021529811A (ja) * 2018-07-11 2021-11-04 クレキシオ バイオサイエンシーズ エルティーディー． 局所用デトミジン製剤
IL287130B (en) 2019-05-01 2022-08-01 Clexio Biosciences Ltd Methods for treating itching
US20220249465A1 (en) * 2019-05-31 2022-08-11 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
MX9304075A (es) * 1992-07-08 1994-04-29 Applied Research Systems Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos.
CN1106259A (zh) 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
CZ20011188A3 (cs) 1998-10-02 2001-08-15 3M Innovative Properties Company Prostředky pro slizniční podání léčiv a jejich použití u zvířat
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
ES2283425T3 (es) 2000-08-03 2007-11-01 Antares Pharma Ipl Ag Nueva composicion para la administracion transdermica y/o transmucosa de compuestos activos que asegura niveles terapeutiocos adecuados.
JP4493203B2 (ja) 2000-12-12 2010-06-30 株式会社ブリヂストン 空気入りタイヤの製造方法
DE10107659B4 (de) 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
DE10256774A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption

Also Published As

Publication number Publication date
HRP20120856T1 (hr) 2012-11-30
SI1811995T1 (sl) 2012-10-30
MX2007005238A (es) 2007-07-09
CA2583876C (en) 2012-05-29
RS52504B (en) 2013-04-30
BRPI0517719B1 (pt) 2018-11-06
WO2006048501A1 (en) 2006-05-11
NO20072864L (no) 2007-06-05
ES2388442T3 (es) 2012-10-15
AU2005300451A1 (en) 2006-05-11
NO338158B1 (no) 2016-08-01
US20070299121A1 (en) 2007-12-27
US20110071203A1 (en) 2011-03-24
JP2008519012A (ja) 2008-06-05
NZ554521A (en) 2010-09-30
AU2005300451B2 (en) 2011-01-20
KR101257672B1 (ko) 2013-04-24
EP1811995B1 (en) 2012-07-25
EP1811995A1 (en) 2007-08-01
US7863311B2 (en) 2011-01-04
AR054987A1 (es) 2007-08-01
BRPI0517719A (pt) 2008-10-21
IL182541A0 (en) 2007-09-20
IL182541A (en) 2011-02-28
JP4996472B2 (ja) 2012-08-08
PL1811995T3 (pl) 2012-12-31
CA2583876A1 (en) 2006-05-11
PT1811995E (pt) 2012-08-03
KR20070085284A (ko) 2007-08-27
DK1811995T3 (da) 2012-08-20
ZA200703486B (en) 2008-06-25
US8309591B2 (en) 2012-11-13

Similar Documents

Publication Publication Date Title
NO2019033I1 (no) regorafenib
BRPI0613033A2 (pt) composição oral
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
BRPI0511900A (pt) composições farmacêuticas
FR2862654B1 (fr) Composition amylacee filmogene
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
DE602005020680D1 (de) Mikrobizide Zusammensetzung
NO20053161D0 (no) Mikrobedrepende sammensetning.
MA29012B1 (fr) N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues
NO20055686D0 (no) Sammensetning
DE602005008726D1 (de) Verwendet
MA28801B1 (fr) Composition antihistaminique
FI20041425A0 (fi) Transmukosaalinen veterinäärinen koostumus
DK1931309T3 (da) Antimykotisk sammensætning
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
DK1612200T3 (da) Gødningssammensætning
DE602005015634D1 (de) Kautschukzusammensetzung
DE602005023936D1 (de) Kühlmittelzusammensetzung
SE0302495L (sv) Transportkomposition
DK1793692T3 (da) Antimikrobiel sammensætning
ITMI20041763A1 (it) Nuove formulazioni iniettabili contenenti progesterone
FI20041057A (fi) Pelkistysainekoostumus
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
FR2871686B1 (fr) Composition anti-decoloration
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina

Legal Events

Date Code Title Description
FD Application lapsed